|
|
|
|
|
|
|
Huntington's disease news
|
|
|
|
|
|
|
Giu 29, 2016
Early exposure to the HD protein may cause life-long symptoms
When the ‘healthy’ HD gene functions as it should, one of its many jobs is in the development of normal embryos. Researchers have long assumed that the ‘mutant’ HD gene inherited by people with HD is still able to do this job, since HD patients develop normally and don’t show signs until later in life.
|
|
Giu 24, 2016
Is this the drug answer to Alzheimer’s and Huntington’s disease?
With a $44 million investment, a group of investors is betting that a Stanford University spinout has a drug that potentially could interfere earlier in the process of knotty neurodegenerative diseases such as Alzheimer’s.
|
|
Giu 23, 2016
Is Huntington’s disease more common than we thought?
More people may have the potential to develop Huntington’s disease than previously thought, according to a study published in the June 22, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
|
|
Giu 22, 2016
Prana’s Huntington Disease trial analysis to feature at global movement disorder conference
Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) is pleased to announce that further analysis of the results of its REACH2HD trial to treat Huntington Disease will be featured at the 20th Annual International Movement Disorder Society Congress.
|
|
Giu 22, 2016
Electron beam snaps best images yet of Huntington’s disease protein.
Figuring out the shape of a protein can help scientists understand how it works and what goes wrong in disease. Huntingtin, the protein that causes Huntington’s disease, has been an elusive target. A recent study using electron microscopes offers a striking glimpse of huntingtin, paving the way for future work
|
|
Giu 22, 2016
WAVE Life Sciences Receives Orphan Drug Designation from FDA for its Lead Candidate Designed to Treat Huntington’s Disease
a genetic medicines company focused on developing stereopure nucleic acid therapies for patients impacted by rare diseases, today announced that its lead candidate WVE-120101, which is being investigated for the treatment of Huntington’s disease (HD), has received Orphan Drug Designation by the U.S. Food and Drug Administration (FDA)
|
|
Giu 21, 2016
New brain map could enable novel therapies for autism and Huntington’s disease
USC scientists have mapped an uncharted portion of the mouse brain to explain which circuit disruptions might occur in disorders such as Huntington’s disease and autism.
|
|
|
|
|
|
|
|
|
